Nagaraj Manickam

808 total citations
16 papers, 676 citations indexed

About

Nagaraj Manickam is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Nagaraj Manickam has authored 16 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Immunology. Recurrent topics in Nagaraj Manickam's work include Nitric Oxide and Endothelin Effects (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Mast cells and histamine (3 papers). Nagaraj Manickam is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Mast cells and histamine (3 papers). Nagaraj Manickam collaborates with scholars based in India, United States and France. Nagaraj Manickam's co-authors include Yves Gorin, Jeffrey L. Barnes, Karen Block, Corry D. Bondi, Hanna E. Abboud, Viswanathan Mohan, Muthuswamy Balasubramanyam, David W. Essex, Kathy K. Griendling and Xiuhua Sun and has published in prestigious journals such as Scientific Reports, Journal of the American Society of Nephrology and British Journal of Haematology.

In The Last Decade

Nagaraj Manickam

16 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nagaraj Manickam India 12 246 135 110 102 93 16 676
Fabio Gianiorio Italy 9 220 0.9× 109 0.8× 211 1.9× 56 0.5× 156 1.7× 10 706
Xuewang Li China 17 292 1.2× 136 1.0× 394 3.6× 134 1.3× 110 1.2× 81 915
Wenda Ramma United Kingdom 13 268 1.1× 202 1.5× 86 0.8× 48 0.5× 42 0.5× 14 870
Kumiko Torisu Japan 14 302 1.2× 72 0.5× 197 1.8× 72 0.7× 80 0.9× 44 837
Dhanunjay Mukhi United States 16 371 1.5× 88 0.7× 299 2.7× 97 1.0× 94 1.0× 27 853
Pablo Cannata Spain 11 373 1.5× 93 0.7× 182 1.7× 223 2.2× 69 0.7× 14 879
Paola Vallerio Italy 16 228 0.9× 75 0.6× 73 0.7× 110 1.1× 68 0.7× 40 791
Qi Bian China 13 322 1.3× 122 0.9× 223 2.0× 73 0.7× 34 0.4× 25 681
Kerstin Ebefors Sweden 17 282 1.1× 107 0.8× 509 4.6× 134 1.3× 95 1.0× 35 912

Countries citing papers authored by Nagaraj Manickam

Since Specialization
Citations

This map shows the geographic impact of Nagaraj Manickam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagaraj Manickam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagaraj Manickam more than expected).

Fields of papers citing papers by Nagaraj Manickam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagaraj Manickam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagaraj Manickam. The network helps show where Nagaraj Manickam may publish in the future.

Co-authorship network of co-authors of Nagaraj Manickam

This figure shows the co-authorship network connecting the top 25 collaborators of Nagaraj Manickam. A scholar is included among the top collaborators of Nagaraj Manickam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagaraj Manickam. Nagaraj Manickam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Venkatesan, S., et al.. (2023). Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats. Journal of Lipid and Atherosclerosis. 12(3). 290–290. 3 indexed citations
3.
Venkatesan, S., et al.. (2022). IDF21-0158 Aegeline mitigates high glucose induced renal cell fibrosis by alleviating ROS generation & augmenting hydrogen sulphide. Diabetes Research and Clinical Practice. 186. 109633–109633. 2 indexed citations
4.
Gokulakrishnan, Kuppan, et al.. (2021). Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin. Molecular Biology Reports. 48(5). 4093–4106. 14 indexed citations
5.
Subramanian, Savitha, Ranjit Mohan Anjana, Muthuswamy Balasubramanyam, et al.. (2020). Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index. Journal of Endocrinological Investigation. 44(7). 1395–1405. 24 indexed citations
6.
Anjana, Ranjit Mohan, Rajendra Pradeepa, Mohan Deepa, et al.. (2020). Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown. Diabetes Technology & Therapeutics. 22(7). 527–534. 52 indexed citations
7.
Ghanate, Avinash, Prabu Paramasivam, Nagaraj Manickam, et al.. (2020). Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy. Scientific Reports. 10(1). 2970–2970. 2 indexed citations
8.
Venkatesan, S., et al.. (2020). Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway. Scientific Reports. 10(1). 16005–16005. 19 indexed citations
9.
Balasubramanyam, Muthuswamy, et al.. (2018). Sestrin2 regulates monocyte activation through AMPK‐mTOR nexus under high‐glucose and dyslipidemic conditions. Journal of Cellular Biochemistry. 120(5). 8201–8213. 41 indexed citations
10.
Paramasivam, Prabu, et al.. (2017). Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury. Clinical Biochemistry. 50(15). 835–842. 15 indexed citations
11.
Manickam, Nagaraj, et al.. (2014). RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. American Journal of Physiology-Renal Physiology. 307(2). F159–F171. 109 indexed citations
12.
13.
Manickam, Nagaraj, Shafeeque Ahmad, & David W. Essex. (2011). Vicinal thiols are required for activation of the αIIbβ3 platelet integrin. Journal of Thrombosis and Haemostasis. 9(6). 1207–1215. 26 indexed citations
14.
Bondi, Corry D., Nagaraj Manickam, Karen Block, et al.. (2009). NAD(P)H Oxidase Mediates TGF-β1–Induced Activation of Kidney Myofibroblasts. Journal of the American Society of Nephrology. 21(1). 93–102. 257 indexed citations
15.
Manickam, Nagaraj, Xiuhua Sun, Kevin Hakala, Susan T. Weintraub, & David W. Essex. (2008). Thiols in the αIIbβ3 integrin are necessary for platelet aggregation. British Journal of Haematology. 142(3). 457–465. 18 indexed citations
16.
Manickam, Nagaraj, Xiuhua Sun, Mengru Li, Yair Gazitt, & David W. Essex. (2007). Protein disulphide isomerase in platelet function. British Journal of Haematology. 140(2). 223–229. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026